Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast ...

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

The therapy uses the patients’ own dendritic cells to initiate an immune response and attack cancer cells. Dendreon ...

The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

A pilot study incorporating HER2-directed dendritic cells into neoadjuvant therapy of early stage HER2+ER- breast cancer - ...

Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...

Renowned centers like Immunity Therapy Center (ITC) in Tijuana provide patients with personalized programs that go beyond traditional methods.

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer.

Plinabulin Final Phase 3 Data Published in The Lancet Respiratory Medicine , Demonstrating Overall Survival Benefit in 2L/3L NSCLC EGFR Wild ...

Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen ...